(Q37012904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Doxazosin in metabolically complicated hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

main subject

arterial hypertension

0 references

author

Stefano Del Prato

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

Giuseppe Penno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Giulia Dell'Omo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Roberto Pedrinelli

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Cardiovascular Therapy

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1027-1035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Prevalence of the metabolic syndrome among Italian adults according to ATP III definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

The link between abdominal obesity, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Treating the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Clinical ease of using doxazosin in BPH patients with and without hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Alpha1-adrenergic blockers: current usage considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Alpha 1-adrenoceptors: function and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

The antihypertensive effects of doxazosin: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Effect of doxazosin on fibrinolysis in hypertensive patients with and without insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Effect of doxazosin on insulin resistance in hypertensive patients with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

The vascular effects of doxazosin in hypertension complicated by metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Old antihypertensives and new diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Long-term survival after heart failure: a contemporary population-based perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.6.1027

10.1586/14779072.5.6.1027

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18035918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference